John K. Field

Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening

Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer

Lung Cancer Screening Program Quality Indicators—Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process Study

AI integrations with lung cancer screening: Considerations in developing AI in a public health setting

Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY)

Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job‐Exposure Matrix (CANJEM) to a combined set of ten case–control studies

Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies

Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies

CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility

Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case‐control studies (<scp>SYNERGY</scp>)

Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case–Control Studies (SYNERGY)

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers

Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors

1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

A reply to “Lung cancer outcomes: Are BMI and race clinically relevant?”

Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives

Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort

Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case–Control Studies

Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure–Response Analysis of 14 Case–Control Studies

Protein-altering germline mutations implicate novel genes related to lung cancer development